Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials
Learned, S., Graff, O., Roychowdhury, S., Moate, R., Krishnan, K. R., Archer, G., Modell, J. G., Alexander, R., Zamuner, S., Lavergne, A., Evoniuk, G., Ratti, E.Volume:
26
Language:
english
Journal:
Journal of Psychopharmacology
DOI:
10.1177/0269881111424931
Date:
May, 2012
File:
PDF, 1.70 MB
english, 2012